Cystic fibrosis newborn screening: Shifting the key question from "should we screen?" to "how should we screen?"

Pediatrics

Volumn 113, Issue 6 I, 2004, Pages 1811-1812

  Farrell, Philip M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN;

BLOOD ANALYSIS; CLINICAL PRACTICE; CLINICAL PROTOCOL; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DETERMINATION; EARLY DIAGNOSIS; GENE MUTATION; HUMAN; NEWBORN SCREENING; NOTE; PRIORITY JOURNAL; PROBABILITY; RELIABILITY; RISK BENEFIT ANALYSIS; SWEAT TEST; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; HUMANS; INFANT, NEWBORN; MUTATION; NEONATAL SCREENING; TRYPSINOGEN;

EID: 2542622141     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.6.1811     Document Type: Note

References (10)

1. Comeau AM, Parad RB, Dorkin HL, et al. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics. 2004;113:1573-1581
2. Farrell MH, Farrell PM. Newborn screening for cystic fibrosis: ensuring more good than harm. J Pediatr. 2003;143:707-712
3. Centers for disease control and prevention. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development. Proceedings of a 1997 workshop. MMWR Recomm Rep. 1997;46(RR-16):1-24
4. Koscik RL, Farrell PM, Kosorok MR, et al, Cognitive function of children with cystic fibrosis: deleterious effect of malnutrition. Pediatrics. 2004: In press
5. Farrell PM. Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Adv Pediatr. 2000;47:79-115
6. Hammond KB, Abman SH, Sokol RJ, Accurso PJ. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med. 1991;325:769-774
7. Farrell PM, Aronson RA, Hoffman GL, Laessig, RH. Newborn screening for cystic fibrosis in Wisconsin: first application of population-based molecular genetics testing. Wis Med J. 1994;93:415-421
8. Farrell PM, Koscik RE, Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis. Pediatrics. 1996;97:524-528
9. Bobadilla JL, Farrell MH, Farrell PM. Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through neonatal screening. Adv Pediatr. 2002;49:131-190
10. Farrell PM, Fost NC. Prenatal screening for cystic fibrosis: Where are we now? J Pediatr. 2002;141:758-763